HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?

CLOSE GLYCEMIC CONTROL REDUCES DIABETIC NEUROPATHY

Even 8 years after the cessation of intensive therapy, patients treated aggressively to keep their blood glucose levels near normal for an average of 6 years continue to show a lower risk for developing neuropathy compared to those treated with conventional therapy, said study coordinator Catherine Martin of the University of Michigan, Ann Arbor.

The findings are part of an 8-year observational study called the Epidemiology of Diabetes Interventions and Complications, a follow-up of the 1993 report on the Diabetes Control and Complications Trial (DCCT) initiated 20 years ago. The DCCT involved 1,441 people in a comparison of intensive and conventional diabetes controls.

"The take-home message is that good glucose control should be started as early as possible," Martin said in a written statement.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?